Asia Pacific Cardiovascular Needle Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Round-Bodied Needles, and Cutting Needles); Application (Open Heart Surgery, and Cardiac Valve Procedures); Usage (Single Use, and Multiple Uses); End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Cardiovascular Centers)
Market Introduction
The cardiovascular needles are used during a number of cardiovascular surgeries such as open-heart surgery, cardiac valve procedures, heart transplant, coronary artery bypass graft surgery, and many more surgeries need surgical needles. These cardiovascular needles are of two types: single use or eyeless needles and multiple use or eyed needles. Cardiovascular needles are manufactured from new stainless-steel alloys containing high concentrations of nickel, Surgalloy and Ethalloy.
Thus, the increasing prevalence of cardiovascular diseases are expected to create a significant demand for cardiovascular needle in the coming years, which is further anticipated to drive the cardiovascular needle market.
The outbreak has severely affected the medical tourism industry in Asia pacific and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure, restrictions imposed by hospitals to the suppliers, decreasing in demand of cardiovascular surgical instruments and others. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent the disease transmission. These restrictive measures are anticipated to impact the supply chain and the availability of medical devices in these countries. It has affected disposable incomes and has also resulted in unemployment. Furthermore, business strategies such as acquisitions, mergers, and partnerships are adversely affected by the imposition of complete lockdown. Such obstructions in business activities are projected to hamper the manufacturing and distribution of several cardiovascular surgical instruments. However, increasing vaccination across the region and availability of government reimbursement policies for various cardiovascular procedures is expected to normalize the situation in Asia Pacific region and will gradually increase the demand for cardiovascular needles.
Get more information on this report :
Market Overview and Dynamics
The cardiovascular needle market in Asia Pacific is expected to grow from US$ 18,861.5 thousands in 2021 to US$ 31,968.6 thousands by 2028; it is estimated to grow at a CAGR of 7.8% from 2021 to 2028. The prevalence of cardiovascular conditions is significantly rising in developing countries due to shift in lifestyle, and the modernization of commercial, industrial, and residential infrastructure; the modernized facilities result in reduced physical activities. On the other hand, stress levels continue to rise among people. Thus, these factors are driving the prevalence of cardiovascular conditions in developing countries. Further, these countries are significantly developing their healthcare facilities and services and are heading toward technological advancements. For instance, structural heart is in initial stages of development in Asia Pacific, the Middle East, and Africa. In India, Kim Hospital provides therapeutic services for structural heart disease. As per the study Global Burden of Disease in the Lancet, ~10 deaths across the world are associated with this disease, which is equivalent to ~6.4 million deaths. China, India, the US, and Russia collectively contributed ~50% to this number in 2015. Also, according to the statistic, the incidences of the structural heart disease is likely to increase in Asia in the coming years.
Key Market Segments
In terms of type, the round-bodied needles segment accounted for the largest share of the Asia Pacific cardiovascular needle market in 2020. In terms of application, the open-heart surgery segment accounted for the largest share of the Asia Pacific cardiovascular needle market in 2020. In terms of usage, the single use segment accounted for the largest share of the Asia Pacific cardiovascular needle market in 2020. In terms of end user, the hospitals and clinics segment accounted for the largest share of the Asia Pacific cardiovascular needle market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the cardiovascular needle market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Ethicon (Johnson & Johnson Services, Inc.), MANI, INC., Barber of Sheffield, FSSB surgical needles GmbH, Medtronic, Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., Aurolab, CP Medical, and SMB Corporation of India.
Reasons to buy report
- To understand the Asia Pacific Cardiovascular needle market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific Cardiovascular needle market
- Efficiently plan M&A and partnership deals in Asia Pacific Cardiovascular needle market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific Cardiovascular needle market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Asia Pacific region.
Asia Pacific Cardiovascular Needle Market Segmentation
By Application
- Open Heart Surgery
- Cardiac Valve Procedures
By Usage
- Single Use
- Multiple Uses
By End User
- Hospitals and Clinics
- Ambulatory Surgical Centres
- Cardiovascular Centres
By Country
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Companies Mentioned
- Ethicon (Johnson & Johnson Services, Inc.)
- MANI, INC
- Barber of Sheffield
- FSSB surgical needles GmbH
- Medtronic
- Teleflex Incorporated
- Meril Life Sciences Pvt. Ltd.
- CP Medical
- SMB Corporation of India
- Aurolab
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Cardiovascular Needle Market – By Type
1.3.2 Cardiovascular Needle Market – By Application
1.3.3 Cardiovascular Needle Market – By Usage
1.3.4 Cardiovascular Needle Market – By End User
1.3.5 Asia Pacific Cardiovascular Needle Market – By Country
2. Asia Pacific Cardiovascular Needle Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Cardiovascular Needle Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cardiovascular Needle Market- Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Cardiovascular Needle Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cardiovascular Diseases
5.1.2 Rise in Elderly Population
5.2 Key Market Restraints
5.2.1 Preference for Surgical Staples over Needles
5.3 Key Market Opportunities
5.3.1 Growth Opportunities in Developing Nations
5.4 Future Trends
5.4.1 Proliferation of MedTech Industry
5.5 Impact Analysis
6. Cardiovascular Needle Market – Asia Pacific Analysis
6.1 Asia Pacific Cardiovascular Needle Market Revenue Forecasts and Analysis
7. Asia Pacific Cardiovascular Needle Market Analysis and Forecasts To 2028 – By Type
7.1 Overview
7.2 Cardiovascular Needle Market Revenue Share, by Type (2020 and 2028)
7.3 Round-Bodied Needles
7.3.1 Overview
7.3.2 Round-Bodied Needles: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
7.4 Cutting Needles
7.4.1 Overview
7.4.2 Cutting Needles: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
8. Asia Pacific Cardiovascular Needle Market Analysis and Forecasts To 2028 – By Application
8.1 Overview
8.2 Cardiovascular Needle Market Revenue Share, by Application (2020 and 2028)
8.3 Open Heart Surgery
8.3.1 Overview
8.3.2 Open Heart Surgery: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
8.4 Cardiac Valve Procedures
8.4.1 Overview
8.4.2 Cardiac Valve Procedures: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
9. Asia Pacific Cardiovascular Needle Market Analysis and Forecasts To 2028 – By Usage
9.1 Overview
9.2 Cardiovascular Needle Market Revenue Share, by Usage (2020 and 2028)
9.3 Single Use
9.3.1 Overview
9.3.2 Single Use: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
9.4 Multiple Use
9.4.1 Overview
9.4.2 Multiple Use: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
10. Asia Pacific Cardiovascular Needle Market Analysis and Forecasts To 2028 –By End user
10.1 Overview
10.2 Cardiovascular Needle Market Revenue Share, by End User (2020 and 2028)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
10.5 Cardiovascular Centers
10.5.1 Overview
10.5.2 Cardiovascular Centers: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
11. Cardiovascular Needle Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 Asia Pacific: Cardiovascular Needle Market
11.1.1 Overview
11.1.2 Asia Pacific: Cardiovascular Needle Market, by Country, 2021 & 2028 (%)
11.1.2.1 China: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.1.1 China: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.1.2 China: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)
11.1.2.1.3 China: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)
11.1.2.1.4 China: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)
11.1.2.1.5 China: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)
11.1.2.2 Japan: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.2.1 Japan: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.2.2 Japan: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)
11.1.2.2.3 Japan: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)
11.1.2.2.4 Japan: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)
11.1.2.2.5 Japan: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)
11.1.2.3 India: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.3.1 India: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.3.2 India: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)
11.1.2.3.3 India: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)
11.1.2.3.4 India: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)
11.1.2.3.5 India: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)
11.1.2.4 Australia: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.4.1 Australia: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.4.2 Australia: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)
11.1.2.4.3 Australia: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)
11.1.2.4.4 Australia: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)
11.1.2.4.5 Australia: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)
11.1.2.5 South Korea: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.5.1 South Korea: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.5.2 South Korea: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)
11.1.2.5.3 South Korea: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)
11.1.2.5.4 South Korea: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)
11.1.2.5.5 South Korea: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)
11.1.2.6 Rest of Asia Pacific: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.6.1 Rest of Asia Pacific: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.6.2 Rest of Asia Pacific: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)
11.1.2.6.3 Rest of Asia Pacific: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)
11.1.2.6.4 Rest of Asia Pacific: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)
11.1.2.6.5 Rest of Asia Pacific: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)
12. Impact Of COVID-19 Pandemic on Asia Pacific Cardiovascular Needle Market
12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
14. Company Profiles
14.1 Ethicon (Johnson & Johnson Services, Inc.)
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 MANI,INC
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Barber of Sheffield
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 FSSB surgical needles GmbH
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Medtronic
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Teleflex Incorporated
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Meril Life Sciences Pvt. Ltd.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 CP Medical
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 SMB Corporation of India
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Aurolab
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. China: Cardiovascular Needle Market, By Type – Revenue and Forecast to 2028 (USD Thousands)
Table 2. China: Cardiovascular Needle Market, by Application – Revenue and Forecast to 2028 (USD Thousands)
Table 3. China: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)
Table 4. China: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)
Table 5. Japan: Cardiovascular Needle Market, By Type– Revenue and Forecast to 2028 (USD Thousands)
Table 6. Japan: Cardiovascular Needle Market, by Application– Revenue and Forecast to 2028 (USD Thousands)
Table 7. Japan: Cardiovascular Needle Market, by Usage – Revenue and Forecast to 2028 (USD Thousands)
Table 8. Japan: Cardiovascular Needle Market, by End User – Revenue and Forecast to 2028 (USD Thousands)
Table 9. India: Cardiovascular Needle Market, By Type– Revenue and Forecast to 2028 (USD Thousands)
Table 10. India: Cardiovascular Needle Market, by Application – Revenue and Forecast to 2028 (USD Thousands)
Table 11. India: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)
Table 12. India: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)
Table 13. Australia: Cardiovascular Needle Market, By Type – Revenue and Forecast to 2028 (USD Thousands)
Table 14. Australia: Cardiovascular Needle Market, by Application– Revenue and Forecast to 2028 (USD Thousands)
Table 15. Australia: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)
Table 16. Australia: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)
Table 17. South Korea: Cardiovascular Needle Market, By Type – Revenue and Forecast to 2028 (USD Thousands)
Table 18. South Korea: Cardiovascular Needle Market, by Application – Revenue and Forecast to 2028 (USD Thousands)
Table 19. South Korea: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)
Table 20. South Korea: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)
Table 21. Rest of Asia Pacific: Cardiovascular Needle Market, By Type – Revenue and Forecast to 2028 (USD Thousands)
Table 22. Rest of Asia Pacific: Cardiovascular Needle Market, by Application – Revenue and Forecast to 2028 (USD Thousands)
Table 23. Rest of Asia Pacific: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)
Table 24. Rest of Asia Pacific: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)
Table 25. Glossary of Terms, Cardiovascular Needle Market
LIST OF FIGURES
Figure 1. Cardiovascular Needle Market Segmentation
Figure 2. Asia Pacific Cardiovascular Needle Market Overview
Figure 3. Round-Bodied Needles Segment Held Largest Share of Type in Cardiovascular Needle Market
Figure 4. Japan is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Cardiovascular Needle Market - Asia Pacific PEST Analysis
Figure 6. Cardiovascular Needle Market Impact Analysis of Driver and Restraints
Figure 7. Asia Pacific Cardiovascular Needle Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Cardiovascular Needle Market Revenue Share, by Type (2020 and 2028)
Figure 9. Round-Bodied Needles: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 10. Cutting Needles: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. Cardiovascular Needle Market Revenue Share, by Application (2020 and 2028)
Figure 12. Open Heart Surgery: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. Cardiac Valve Procedures: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. Cardiovascular Needle Market Revenue Share, by Usage (2020 and 2028)
Figure 15. Single Use: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 16. Multiple Use: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. Cardiovascular Needle Market Revenue Share, by End User (2020 and 2028)
Figure 18. Hospitals and Clinics: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. Ambulatory Surgical Centers: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 20. Cardiovascular Centers: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. Asia Pacific: Cardiovascular Needle Market, by Key Country – Revenue (2021) (USD Thousands)
Figure 22. Asia Pacific: Cardiovascular Needle Market, by Country, 2021 & 2028 (%)
Figure 23. China: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
Figure 24. Japan: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
Figure 25. India: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
Figure 26. Australia: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
Figure 27. South Korea: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
Figure 28. Rest of Asia Pacific: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
Figure 29. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Ethicon (Johnson & Johnson Services, Inc.)
- MANI, INC
- Barber of Sheffield
- FSSB surgical needles GmbH
- Medtronic
- Teleflex Incorporated
- Meril Life Sciences Pvt. Ltd.
- CP Medical
- SMB Corporation of India
- Aurolab
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific cardiovascular needle market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific cardiovascular needle market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the cardiovascular needle market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution